The major energy source for most cells is glucose, from which ATP is generated via glycolysis and/or oxidative metabolism. Glucose deprivation activates AMP-activated protein kinase (AMPK) 1 , but it is unclear whether this activation occurs solely via changes in AMP or ADP, the classical activators of AMPK 2-5 . Here, we describe an AMP/ADP-independent mechanism that triggers AMPK activation by sensing the absence of fructose-1,6-bisphosphate (FBP), with AMPK being progressively activated as extracellular glucose and intracellular FBP decrease. When unoccupied by FBP, aldolases promote the formation of a lysosomal complex containing at least v-ATPase, ragulator, axin, liver kinase B1 (LKB1) and AMPK, which has previously been shown to be required for AMPK activation 6,7 . Knockdown of aldolases activates AMPK even in cells with abundant glucose, whereas the catalysis-defective D34S aldolase mutant, which still binds FBP, blocks AMPK activation. Cell-free reconstitution assays show that addition of FBP disrupts the association of axin and LKB1 with v-ATPase and ragulator. Importantly, in some cell types AMP/ATP and ADP/ATP ratios remain unchanged during acute glucose starvation, and intact AMP-binding sites on AMPK are not required for AMPK activation. These results establish that aldolase, as well as being a glycolytic enzyme, is a sensor of glucose availability that regulates AMPK.
(Extended Data Fig. 1d-f ). Combined starvation of MEFs for glucose, glutamine and serum (leaving them with no major carbon source) caused a rapid, 1.8-fold activation of AMPK within 15 min, followed by a much larger activation for up to 2 h, while only the initial activation was observed if glutamine was still present (Fig. 1c) ; these changes correlated with phosphorylation of AMPK and ACC (Extended Data Fig. 1g , h). Intracellular AMP/ATP and ADP/ATP ratios were not altered significantly on removal of glucose alone, but on removing glucose and glutamine they increased after 30 min, correlating with delayed AMPK activation ( Fig. 1d ; Extended Data Fig. 1i ). Notably, the presence or absence of serum yielded different patterns of AMPK activation upon starvation for glucose or glucose plus glutamine (compare Fig. 1c and Extended Data Fig. 1j ; see Supplementary Note 1). We also studied HEK293 cells that stably expressed FLAG-tagged wild-type AMPKγ 2 or the R531G mutant, which is not activated by treatments that increase cellular AMP or ADP 9 . In R531G cells, the rapid effect of removing glucose was still present, whereas the delayed effect of also removing glutamine was essentially absent ( Fig. 1e-h ; Extended Data Fig. 1k , l; Supplementary Note 2). Thus, glucose starvation activates AMPK by an AMP/ADP-independent mechanism, whereas removal of all carbon sources activates AMPK by the canonical AMP/ADPdependent mechanism. The latter effect takes place after a delay of 20-30 min, which may represent the time taken to metabolize pyruvate in the medium and/or cellular nutrient reserves.
We next tested the effects of nutrient removal in Axin −/− or Lamtor1 −/− MEFs, and found that acute (20 min) AMPK activation on removal of glucose or glucose plus glutamine was completely abolished, while the larger effects of removing both carbon sources at 2 h were unchanged ( Fig. 2a, b ; Extended Data Fig. 2a-c) . Unlike wildtype AMPKβ 2, re-introduction to knockout HEK293 cells of a G2A mutant (which prevents the N-myristoylation required for glucose starvation to cause AMPK accumulation in 'perinuclear speckles' 8, 10 ) did not restore the ability of glucose removal to activate AMPK or to promote its translocation to lysosomes ( Fig. 2c, d , Extended Data Fig. 2e, f) . Similar results were obtained with AMPKβ 1 (Extended Data Fig. 2g ). By contrast, knock-down of Camkk2 (the alternative upstream kinase for AMPK), expression of the AMPKβ 2-S108A mutation (which disrupts the ' ADaM' binding site for allosteric activators such as A769662 and 991 11, 12 ) or expression of the LKB1-C433S mutation (which prevents the C-terminal farnesylation essential for maximal AMPK activation by energy stress 13 ) had no effect on glucose starvation-induced AMPK activation ( Fig. 2c , e; Extended Data Fig.  2d ). Thus, by several criteria, AMPK activation by glucose removal occurs via a mechanism distinct from that involved in the effects of energy stress or ADaM site ligands.
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We next analysed whether it is lack of glucose itself, or deficiency of a downstream metabolite (Extended Data Fig. 3a) , that is responsible for AMPK activation. We first knocked down hexokinases (HK1 and HK2) in HEK293T cells, which caused marked phosphorylation of AMPK and ACC even in high-glucose medium (Fig. 3a) . However, intermediates in the pentose phosphate, serine biosynthesis or hexosamine pathways did not appear to be involved in AMPK regulation (Extended Data Fig. 3b-d ). As AMPK was still activated by glucose deprivation even in medium containing 1 mM pyruvate ( Fig. 1 ; Extended Data Fig. 1 ), this left a glycolytic intermediate as the most likely regulator of AMPK. To test this, we used cell-free reconstitution assays involving complex formation between LAMTOR1, axin-LKB1 and AMPK 6 . Of the eleven intermediates from glucose to pyruvate, only FBP caused dissociation of axin-LKB1 and AMPKα from LAMTOR1 in a fraction containing lysosomal membranes from glucose-starved MEFs ( Fig. 3b ; Extended Data Fig. 4a, b ). The intracellular levels of FBP in mouse liver decreased markedly, from 9.7 ± 1.9 to 2.3 ± 1.2 μ M, after starvation for 16 h (Extended Data Fig. 4c ). Notably, 10 μ M FBP was able to cause complete dissociation of axin-LKB1 from LAMTOR1 (Fig. 3c ). The relationship between the concentrations of medium or plasma glucose and intracellular FBP was linear, both in MEFs and in liver in vivo (Extended Data Fig. 4d -h).
To confirm that FBP represses AMPK activation, we introduced it into glucose-starved cells permeabilized with streptolysin O (SLO) (Extended Data Fig. 4i ). Addition of 10 μ M FBP to the SLO-treated cells reduced AMPK phosphorylation under glucose starvation conditions ( Fig. 3d ). Addition of intermediates upstream or downstream of FBP had similar effects, except for pyruvate, which cannot be converted back to FBP in these cells (Extended Data Fig. 4j ). However, intermediates upstream of FBP failed to suppress AMPK in SLO-permeabilized MEFs with knockdown of phosphofructokinase-1 (PFK1-KD, triple knockdown of Pfkp, Pfkm and Pfkl), while intermediates downstream of FBP failed to suppress AMPK in SLO-permeabilized MEFs with knockdown of triose-phosphate isomerase (TPI-KD) (Extended Data Fig. 4k , l). Furthermore, inhibiting FBP production by knocking down PFK1 or overexpressing fructose-1,6-bisphosphatase (FBP1) led to AMPK phosphorylation even in high-glucose conditions (Extended Data Fig. 5a, b ). By contrast, promoting formation of FBP by overexpressing PFKP impaired AMPK activation in low-glucose conditions (Extended Data Fig. 5c ). Knockdown of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) had no effect on AMPK activation (Extended Data Fig. 5d ).
We next investigated which protein acts as the FBP sensor responsible for regulating AMPK. FBP is a substrate for aldolases (ALDOA-C) and an allosteric activator of pyruvate kinase 14 . Knockdown of aldolases causes cell death 15 , so ALDOA-C was first expressed under a doxycycline-inducible promoter before successive knockdown of the three endogenous isoenzymes, and doxycycline was then withdrawn to trigger almost complete aldolase depletion (Extended Data Fig. 6a -c). The triple knockdown (ALDO-TKD) caused AMPK activation even in high-glucose medium ( Fig. 4a ; Extended Data Fig. 6d ), whereas knocking down pyruvate kinases (Pkm and Pklr) had no effect (Extended Data Fig. 6e ). Triple knockdown of aldolases did not alter AMP/ATP or ADP/ATP ratios (Extended Data Fig. 6f ). Moreover, the effects of aldolase knockdown on AMPK activation and formation of AMPK-activating complexes were blocked in Axin −/− , Lamtor1 −/− and Lkb1 −/− MEFs, but intact in Camkk2 −/− MEFs ( Fig. 4b ; Extended Data Figs 6g-k, 7) , confirming that aldolase exerts its effects through the lysosomal pathway. Importantly, FBP, even at 200 μ M, failed to dissociate axin-LKB1 from LAMTOR1 in light organelles isolated from glucose-starved, aldolase-deficient MEFs, or to block glucose starvation-induced AMPK activation in SLOpermeabilized, aldolase-deficient MEFs (Extended Data Fig. 6l , m). These results show that aldolase is required for FBP to prevent AMPK activation. Neither fructose-1-phosphate (an alternative aldolase substrate) nor fructose-2,6-bisphosphate dissociated axin-LKB1 | Glucose deprivation activates AMPK via an AMP/ADPindependent mechanism. a, MEFs were grown in full medium and then switched to medium containing reduced concentrations of glucose for 4 h and AMPK activity in immunoprecipitates was measured (n = 3; asterisks show significant differences from 25 mM glucose). b, MEFs were incubated as in a, or in full medium with 300 μ M berberine (Ber) for 1 h, and intracellular AMP/ATP and ADP/ATP ratios determined by liquid chromatography with mass spectrometry (LC-MS). n = 3; asterisks show significant differences from control with 25 mM glucose. c, MEFs were grown in full medium and then incubated overnight in the same medium but with 5 mM glucose. At time zero, medium was removed and replaced with the same medium (+ Glc+ Gln), medium lacking glucose only (−Glc+ Gln), or medium lacking glucose and glutamine (−Glc−Gln), all without serum. AMPK was isolated by immunoprecipitation (IP) and kinase activity determined. n = 4; asterisks show significant differences from control (+ Glc+ Gln); daggers ( †) show significant differences between − Glc+ Gln and − Glc− Gln samples at the same time point. d, AMP/ATP ratios under the same conditions as in c. n = 3; statistical significance as in c. e, g, As in c, but using HEK293 cells expressing wildtype (WT) FLAG-tagged AMPKγ 2 (e) or an AMP/ADP-insensitive R531G (RG) mutant 9 (g). n = 4 (e), n = 2 (g); statistical significance as in c. f, h, As in d, but using HEK293 cells expressing wild-type FLAG-tagged AMPKγ 2 (f) or the R531G mutant (h). n = 3; statistical significance as in c. All results shown as mean ± s.d. * / †P < 0.05, * * P < 0.01, * * * / † † †P < 0.001, * * * * / † † † †P < 0.0001, by ANOVA. All experiments were performed at least twice.
letter reSeArCH from LAMTOR1 (Extended Data Fig. 6n ), indicating that FBP is the unique intermediate that modulates aldolase to sense availability of glucose.
As final confirmation of this theory, we made use of an ALDOA mutation (D34S) that does not significantly affect the Michaelis constant (K m ) for FBP, but dramatically reduces the catalytic constant (k cat ) for conversion of FBP to dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P) 16, 17 . FBP would therefore accumulate in the active site of this mutant, even when glucose availability was low. Supporting this idea, intracellular levels of FBP were slightly (but significantly (P = 0.023)) higher on glucose starvation of HEK293T cells expressing the D34S mutant than in cells expressing wild-type ALDOA (Extended Data Fig. 8a ). As expected, AMPK activation and formation of the ragulator-axin-LKB1-AMPK complex were markedly impaired in HEK293T cells or ALDO-TKD MEFs expressing this mutant ( Fig. 4c ; Extended Data Fig. 8b, c) . Furthermore, the levels of p-AMPK and p-ACC were greatly reduced in starved mice injected with adenovirus expressing the D34S mutant compared to wild-type aldolase (Extended Data Fig. 8d ). By contrast, when wild-type ALDOA was expressed in ALDO-TKD MEFs, it restored the response of AMPK to glucose availability, whereas the K230A mutant, which cannot form the initial Schiff base with FBP and would thus not undergo the conformational change induced by FBP 16, 18, 19 , failed to do this ( Fig. 4d ; Extended Data Fig. 8e -g).
This study defines FBP as the critical metabolite that signals glucose availability, and provides strong evidence that aldolases are the sensors that transmit the signal to AMPK. In MEFs and HEK293T cells, FBP was almost entirely derived from glucose (Extended Data Fig. 9 ), and the intracellular concentrations of FBP correlated with medium or plasma glucose (Extended Data Fig. 4g , h). We propose that aldolase, as a natural FBP receptor, transmits the effects of glucose shortage to AMPK via the v-ATPase-ragulator-axin-LKB1 complex (Extended Data Fig. 10a ). Knockdown of aldolase triggers formation of this complex even in high-glucose conditions, like pharmacological inhibition of v-ATPase 6 . Intriguingly, yeast and mammalian aldolases (Fba1 and ALDOA/B/C) interact physically with various subunits of v-ATPase and are required for assembly and activity of the v-ATPase complex [20] [21] [22] [23] . Our co-precipitation assays confirmed that aldolase interacts with v-ATPase and ragulator in HEK293T cells (Extended Data Fig. 10b ).
According to our model, aldolase would function as a surveillance system, sensing a fall in glucose availability before any fall in cellular Prior to the experiment (36 h), MEFs were pre-treated with adenoviral vector expressing either Cre recombinase or empty vector. Samples were taken for AMPK assay; n = 4. The lower panels show western blotting of cell lysates using the indicated antibodies. c, Endogenous AMPKβ 2 was knocked out in HEK293 cells by CRISPR-Cas9, and wild-type AMPKβ 2, or the G2A or S108A mutants, were re-expressed by transient transfection. Cells were then treated by removing glucose, or glucose plus glutamine, for 20 min as in a, or with 5 μ M 991 or 300 μ M berberine for 1 h, all without serum. AMPKβ 2 complexes were immunoprecipitated and AMPK activity determined. n = 4; asterisks or exact P values indicate means significantly different from controls (left-hand columns) of the same genotype. d, Glucose starvation causes translocation of AMPKβ 2 to the lysosome in HEK-293 cells that is dependent on N-myristoylation.
The data are derived from the experiment shown in Extended Data Fig. 2f . Pearson correlations between red (lysosomes) and green (AMPK-β 2) stain across the cytoplasm were determined; results are for 7-9 cells under each condition. e, MEFs expressing wild-type LKB1 or a C433S knock-in 13 were incubated with or without glucose and/or glutamine for 20 min, or with DMSO, A769662 (300 μ M) or berberine (300 μ M) for 1 h, all without serum. Endogenous AMPK was immunoprecipitated and assayed (top) or lysates were analysed by western blotting using the indicated antibodies (bottom). n = 4; asterisks or exact P values show results significantly different from controls in full medium (removal of glucose and/or glutamine) or DMSO controls (A769662 and berberine). All results shown as mean ± s.d. * P < 0.05, * * * * P < 0.0001, NS, not significant by ANOVA. All experiments were performed at least twice.
letter reSeArCH energy status occurs, and activating AMPK in an AMP/ADPindependent manner. Aldolases may be ideal sensors of glucose availability because they are not saturated with FBP at normal glucose concentrations, so that FBP availability can be sensed across the entire physiological range (Supplementary Note 3). Once activated, AMPK would promote alternative catabolic pathways to generate ATP, such as fatty acid oxidation. Our findings that cellular energy status was not compromised by glucose removal in MEFs, unless glutamine was also removed, suggest that glucose-deprived MEFs simply switch to oxidative metabolism of glutamine. While AMP promotes the interaction of AMPK with axin 7 , low, basal levels of AMP may be sufficient for AMPK activation via the lysosomal mechanism 6 , whereas higher concentrations (sufficient to cause binding at site 3, the low-affinity site disrupted by the R531G mutation 24 ) may be necessary to trigger the canonical energy-sensing mechanism. Finally, as the budding yeast AMPK orthologue is activated by glucose starvation but is not regulated by AMP 25 , while the interaction between aldolase and v-ATPase is modulated by glucose availability in yeast 22 , we propose that the mechanism for AMPK regulation identified here may reflect its ancestral role in glucose sensing. Fig. 6a . The cells were then incubated in DMEM with or without glucose for 2 h, followed by analysis of p-AMPKα and p-ACC levels. c, d, Activation of AMPK in HEK293T cells stably expressing ALDOA-D34S (c), or in ALDO-TKD MEFs stably expressing ALDOA-K230A (d) were analysed as in a. The experiment in a was performed four times, those in b and d twice, and that in c three times. (PX459) and pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmids #48139 and #48138). Cells were transfected with a 1:1 mixture of GFP and Puro constructs containing the CRISPR oligonucleotides, using 2-3 μ g DNA in Fugene 6 transfection reagent per well of a 6 well plate. After 24 h, transfection was verified by fluorescence microscopy and cells trypsinized from the plates and re-plated into 15-cm dishes in the presence of puromycin (0.6 μ g/ml). After 24 h the medium was changed, fresh puromycin added and cells grown for a further 48 h, at which time cells were transferred to medium without puromycin and allowed to grow until colonies formed. Colonies (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) were picked and expanded until large enough to allow freezing of stocks and analysis of AMPKβ 2 expression by western blot and immunoprecipitate kinase assay. Reagents. Rabbit polyclonal antibody against LAMTOR1 was raised and validated as described previously 6 , and was diluted 1:100 for immunoprecipitation (IP) or 1:500 for immunoblotting (IB). Rabbit polyclonal antibody against PFKM was raised and validated as described previously 26 and was diluted 1:500 for IB. Rabbit anti-phospho-AMPKα -T172 (cat. #2535, 1:1,000 for IB), anti-AMPKα (cat. #2532, 1:1,000 for IB), anti-phospho-ACC-Ser79 (cat. #3661, 1:1,000 for IB), anti-ACC (cat. #3662, 1:1,000 for IB), anti-LKB1 (cat. #3047, 1:1,000 for IB), anti-axin1 (cat. #2074, 1:1,000 for IB), anti-HK1 (cat. #2024, 1:1,000 for IB), anti-HK2 (cat. #2867, 1:1,500 for IB), anti-PFKP (cat. #8164, 1:1,000 for IB), anti-PFKL (cat. #8175, 1:1,000 for IB), anti-G6PD (cat. #12263, 1:1,000 for IB), anti-PKM1/2 (cat. #3190, 1:1,000 for IB), anti-ALDOA (cat. # 8060, 1:2,000 for IB), anti-βtubulin (cat. #2128, 1:1,000 for IB), anti-AMPKβ 1 (cat. #12063), anti-AMPKβ 2 (cat. #4148), anti-HIS (cat. #12698, 1:500 for IB), and HRP-conjugated mouse anti-rabbit IgG (conformation specific, cat. #5127, 1:2,000 for IB) antibodies were purchased from Cell Signaling Technology. In Figs 1, 2 and Extended Data Fig. 1g , total ACC was detected using IR dye 800-conjugated streptavidin (Rockland, cat. #S000-32). Rabbit anti-ALDOB (cat. 18065-1-AP, 1:1,000 for IB) and anti-CaMKK2 (cat. 11549-1-AP, 1:500 for IB) antibodies were purchased from Proteintech. Mouse anti-ALDOC (cat. AM2215b, 1:2,000 for IB) antibody was purchased from Abgent. Rabbit anti-PKLR (cat. ab38240, 1:500 for IB), rat anti-LAMP2 (cat. ab13524; 1:120 for immunofluorescent staining (IF)), mouse anti-LAMP1 (cat. ab25630, 1:120 for IF), mouse anti-aldolase (cat. ab54770, 1:50 for IP), and goat anti-TPI (cat. ab28760, 1:1,000 for IB) antibodies were purchased from Abcam. Mouse anti-PHGDH (cat. AMAB90786, 1:1,000 for IB) and rabbit anti-GAPDH (cat. G9545, 1:1,000 for IB) antibodies were purchased from Sigma. Goat anti-axin (cat. sc-8567, 1:100 for IP and 1:60 for IF), mouse anti-HA (cat. sc-7392, 1:2,000 for IB), anti-LKB1 (cat. sc-32245, 1:100 for IP), and anti-goat IgG-HRP (cat. sc-2354, 1:5,000 for IB) antibodies were purchased from Santa Cruz Biotechnology. The HRP-conjugated goat anti-mouse IgG (cat. 115-035-003, 1:5,000 for IB) and HRP-conjugated goat anti-rabbit IgG (cat. 111-035-003, 1:5,000 for IB) antibodies were purchased from Jackson ImmunoResearch. Glucose (cat. were generated by infecting Lamtor1 F/F , Axin F/F or Lkb1 F/F MEFs with adenoviruses expressing Cre recombinase for 12 h. The infected cells were then incubated in the fresh DMEM for another 8 to 10 h before further treatments. HEK293T cells were obtained from ATCC. HEK293 cells were obtained from Invitrogen. AD293 cells were obtained from Clontech. Cells were verified to be free of mycoplasma contamination and authenticated by STR sequencing. For starvation, cells were rinsed twice with PBS, and then incubated in glucose-free DMEM (Gibco, cat. 11966) supplemented with 10% FBS and 1 mM sodium pyruvate (Gibco, cat. 11360) for desired periods of time at 37 °C. For starvation for glucose plus glutamine, cells were incubated in DMEM without glucose, glutamine, phenol red or pyruvate (Gibco cat. A14430-01) with the addition of 1 mM pyruvate (Lonza cat. BE 13-11 SE) with or without Glutamax (Gibco cat. 35050-038) and d-glucose (Gibco cat. A2494001). To determine the effect of different glycolytic intermediates on affecting AMPK activation in cells, the cells were first permeabilized with SLO as described previously 29 (incubated with SLO for 5 min). After incubating for another 15 min, cells were lysed and were analysed by immunoblotting. Immunoprecipitation and immunoblotting. IP was carried out as described previously 6 . Briefly, 10 × 15-cm dishes of MEFs (grown to 80% confluence) for immunoprecipitating LAMTOR1 or 4 × 15-cm dishes of MEFs (grown to 80% confluence) for immunoprecipitating axin in each lane were collected and lysed with 750 μ l per dish of ice-cold ODG buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2% ODG, 5 mM β -mercaptoethanol with protease inhibitor cocktail). Cell lysates were incubated with respective antibodies overnight. Overnight protein aggregates were pre-cleared by centrifugation at 20,000g for 10 min, and protein A/G beads (1:100 for immunoprecipitating axin and 1:250 for LAMTOR1) were then added to the lysates and mixed for another 3 h. The beads were washed with 100 times volume of ODG buffer three times at 4 °C and then mixed with an equal volume of 2 × SDS sample buffer for immunoblotting. To analyse the levels of p-AMPKα and p-ACC in MEFs, cells grown to 70-80% letter reSeArCH confluence in a well of a 6-well dish were lysed with 250 μ l ice-cold lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β -glycerolphosphate, with protease inhibitor cocktail). The lysates were then centrifuged at 20,000g for 10 min at 4 °C and an equal amount of 2 × SDS sample buffer was added to the supernatant. The levels of p-AMPKα and p-ACC were then analysed by immunoblotting. To analyse the levels of p-AMPKα and p-ACC in liver, freshly excised liver tissue was added with ice-cold lysis buffer (10 μ l/mg liver weight), followed by homogenization and centrifugation as described above. The lysates were then mixed with 2 × SDS sample buffer and then subjected to immunoblotting. Levels of total proteins and the levels of phosphorylation of proteins were analysed on separate gels. The band intensities on developed films were quantified using Image J software (National Institutes of Health Freeware). Fluorescence microscopy. Cells were grown on glass coverslips in 6-well dishes and were cultured to 60-80% confluence. Cells were fixed with 1 ml of 4% formaldehyde (diluted in PBS) at room temperature for 20 min. They were rinsed twice with 1 ml PBS (room temperature) and then permeabilized with 1 ml of 0.1% Triton X-100 (diluted in PBS) for 5 min at 4 °C. Cells were rinsed twice with 1 ml PBS, and were incubated with primary antibodies overnight at 4 °C. The cells were then rinsed three times with 1 ml PBS, and then incubated with Alexa-Fluor 488conjugated anti-goat secondary antibody (Molecular Probes, A11058; diluted 1:100 in PBS) and Alexa-Fluor 594-conjugated anti-rat secondary antibody (Molecular Probes, cat. A21209; diluted 1:100 in PBS) or Alexa-Fluor 594-conjugated antimouse secondary antibody (Molecular Probes, cat. A11032; diluted 1:100 in PBS) for 8 h at room temp in the dark. They were washed four times with 1 ml PBS, and then mounted on slides using ProLong Diamond Antifade Mountant (Molecular Probes, cat. P36970). Cells were imaged under a Zeiss LSM 780. Samples were excited with an Ar gas laser (Zeiss, laser module LGK 7812) using a 488-nm laser line for Alexa-Fluor 488 dye (green channel), and with a HeNe gas laser (Zeiss, LGK 7512 PF) using a 594-nm laser line for Alexa-Fluor 594 dye (red channel). Confocal microscope pictures were taken with a 63 × oil objective. The parameters, including 'PMT voltage' , 'Offset' , 'Pinhole' and 'Gain' , were kept unchanged between each picture taken. For quantitative analyses in Fig. 2d , Pearson's correlations were performed using Volocity 5.2 software, analysing the whole cell but excluding the nucleus. For quantitative analyses in Extended Data Fig. 7a, b , co-localization percentages (determined by Mander's overlap coefficient: the number of pixels from the red channel that overlap with pixels from the green channel divided by the total number of pixels detected in the red channel above the threshold value) were calculated by ZEN 2010 software (Zeiss). Thresholds were set automatically by the software as described 30 . AMPK assays. AMPK was assayed using the AMARA peptide as substrate in resuspended immunoprecipitates made using an equal mixture of anti-AMPKα 1 and -AMPKα 2 antibodies 9 , except for the assays in Fig. 2c and Extended Data Fig. 2g where we immunoprecipitated using anti-AMPKβ 2 and AMPKβ 1 antibodies, respectively, and Fig. 1e , g where we immunoprecipitated using anti-FLAG antibodies. Aldolase assays. The aldolase enzymatic assay was performed as described previously 31 . 3-phosphoglyceraldehyde reacts with hydrazine to form hydrazone that absorbs at 240 nm. In brief, MEFs (80% confluence grown in a 10-cm dish) were collected, washed with PBS, and lysed with 500 μ l digitonin solution (100 μ g/ml PBS). Some 5 μ l of cell lysate was incubated with EDTA (0.1 mM final concentration), iodoacetate (0.2 mM final concentration) and hydrazine (2.33 mM final concentration), and the digitonin solution was added to make a final volume of 300 μ l. A blank read was taken at 240 nm. FBP (5 mM final concentration) was added and the OD 240 was determined at 1-min intervals by a SpectraMax M5 microplate reader (Molecular Device). Enzymatic activity was determined in triplicate and normalized to the control. In vitro reconstitution for lysosomal binding assays. The assays were performed as described previously 6 . Full length His-tagged axin was expressed and purified as described previously 7 . In general, each reconstitution reaction requires light organelles from two 15-cm dishes of MEFs and cytosol from four 15-cm dishes. Cells were scraped and spun down at 200g at room temperature, and then resuspended in 750 μ l per 15-cm dish of fractionation buffer (50 mM KCl, 90 mM K-gluconate, 1 mM EGTA, 5 mM MgCl 2 , 50 mM sucrose, 20 mM HEPES, pH 7.4, supplemented with 2.5 mM ATP, amino acids (Gibco, cat. 11130-077) and protease inhibitor cocktail) at room temperature, and were mechanically broken by spraying six times through a 22G needle, then yielding a post-nuclear supernatant (PNS) by spinning at 2,000g for 5 min. The PNS was then spun at max speed for 15 min in a tabletop centrifuge. The light organelles (the pellets) were thus separated from the cytosol (the supernatants). Light organelles were then re-suspended with 100 μ l fractionation buffer containing glycolytic intermediates as indicated and were incubated at 37 °C in a thermomixer at 400 r.p.m. for 15 min. Some 500 μ l of cytosol or 1 μ g of His-axin was then added to the mixture, followed by incubation at 37 °C for another 25 min. The mixtures were lysed with 800 μ l ODG buffer, followed by IP with antibody against LAMTOR1. CE-MS-based analysis of metabolites. Sample preparation for CE (capillary electrophoresis) -MS was carried out as described previously 32, 33 , with some modifications. In general, each measurement requires cells collected from a 10-cm dish (60-70% confluence) or 100 mg liver tissue. For analysis of metabolites, cells were rinsed with 20 ml of 5% mannitol solution (dissolved in water) and instantly frozen in liquid nitrogen. Cells were then lysed with 1 ml of methanol containing internal standards 1 (IS1 (Human Metabolome Technologies, H3304-1002, 1:200), used to standardize the metabolite intensity and to adjust the migration time), and were scraped off from the dish. For analysis of metabolites in liver, the freshly excised tissue was freeze-clamped first, then washed in pre-cooled 5% mannitol solution and grinded in 1 ml of methanol with 50 μ M IS1. The lysate was then mixed with 1 ml chloroform and 400 μ l water by 20 s of vortexing. After centrifugation at 15,000g for 15 min at 4 °C, 450 μ l of aqueous phase was collected and was then filtrated through a 5-kDa cutoff filter (Millipore, cat. UFC3LCCNB-HMT) by centrifuging at 10,000g for 3 h at 4 °C. Simultaneously, the quality control (QC) sample was prepared by combining 100 μ l of the aqueous phase from each sample and then filtered. The filtered aqueous phase was then freeze-dried in a vacuum concentrator and then dissolved in water containing IS3 (Human Metabolome Technologies, H3304-1104, 1:200) to adjust the migration time. 20 μ l of re-dissolved solution was then loaded into an injection vial with a conical insert for CE-TOF MS (Agilent Technologies 7100, equipped with 6224 mass spectrometer) analysis. Instrumental analysis and data processing were performed as described previously 32, 33 . For quantifying absolute concentrations of FBP, [U-13 C]FBP (10 μ g/ml) was used as internal standard. A standard curve and a two-parameter polynomial equation were generated by plotting the ratios of unlabelled FBP to labelled FBP (peak area:peak area) against the concentrations of unlabelled FBP. The amount of FBP was then estimated according to the equation. The total concentrations of FBP in mouse liver ([FBP] liver ) were obtained by dividing the amount of FBP by the estimated volume of liver. The concentrations of free-state FBP were then estimated, according to the value of [FBP] liver , as described previously 34 . ATP, ADP and AMP detection by LC-MS. The levels of the three compounds (ATP, ADP and AMP) were measured using a TSQ Quantiva interfaced with Ultimate 3000 Liquid Chromatography system (Thermo Scientific), equipped with a porous graphitic carbon column (HyperCarb 30x1mm ID 3 μ m; Part No: C-35003-031030, Thermo Scientific). Mobile phase buffer A consisted of 0.3% (v/v) formic acid adjusted to pH 9 with ammonia before a 1/10 dilution. Mobile phase buffer B was 80% (v/v) acetonitrile. The column was maintained at a controlled temperature of 30 °C and was equilibrated with 10% buffer B for 5 min at a constant flow rate of 0.06 ml/min. Aliquots of 1 μ l of each sample were loaded onto the column and compounds were eluted from the column with a linear gradient of 10-60% buffer B over 9 min. Buffer B was then increased to 100% within 1 min, and the column was washed for a 5 min with 100% Buffer B. Eluents were sprayed into the TSQ Quantiva using Ion Max NG ion source with ion transfer tube temperature set to 350 °C and vaporizer temperature 125 °C. The TSQ Quantiva was run in negative mode with a spray voltage of 2,600, sheath gas 40 and Aux gas 10. Levels of ATP, ADP and AMP were measured using multiple reactions monitoring mode (MRM) with optimised collision energies and radio frequencies previously determined by infusing pure compounds. Three transitions were used to monitor each of the three compounds, ATP (505.92 > 158.98, 505.92 > 408. 12 has no effect on AMPK activation. HEK293T cells were infected with lentivirus expressing siRNA against G6PD (b) or PHGDH (c), or siRNA against GFP as a control; the cells were then incubated in DMEM medium with (25 mM) or without glucose for 2 h, followed by analysis of p-AMPKα and p-ACC levels. d, The hexosamine pathway is not involved in AMPK regulation under glucose deprivation. MEFs were incubated for 2 h in DMEM medium containing GlcNAc (N-acetylglucosamine), a supplement of the hexosamine pathway which cannot be converted back to glucose 35 , at indicated concentrations and 25 mM or 0 mM glucose. Cells were then subjected to immunoblotting. Experiments in b and c were performed twice, and that in d three times.
Extended Data Figure 4 | Absence of FBP defines a starvation signal for AMPK activation. All intact cell experiments were performed in the presence of 10% serum. a, FBP dissociates axin-LKB1 from LAMTOR1 in vitro. The same experiment identical to that in Fig. 3b was performed except that the bacterially expressed His-tagged AXIN was used in lieu of AXIN-containing cytosol and incubated with light organelles purified from MEFs glucose-starved for 2 h. b, FBP modulates the interaction between AMPK and LKB1. Cytosol from unstarved MEFs was mixed with light organelles purified from 2-h glucose-starved ALDO-TKD MEFs or wild-type MEFs, followed by addition of 200 μ M FBP. The mixtures were then dissolved and LKB1 was immunoprecipitated. c, Concentrations of FBP in mouse liver after starvation for 16 h. FBP levels from mouse livers were determined by CE-MS. The amounts of FBP were estimated according to the standard curve generated by plotting the peak-area ratios of unlabelled to 13 C-labelled FBP (derived from [U-13 C]FBP used as internal standard) against the concentrations of unlabelled FBP. The results were obtained by dividing its amount by the estimated volume of liver, and the concentrations of free-state FBP were then estimated as described previously 34 . Values are presented as mean ± s.d., n = 5 for each condition, P = 9.627 × 10 −5 (Student's t-test). d, e, Intracellular FBP levels were measured by CE-MS in MEFs after incubation in media containing different concentrations of glucose (d), or in glucose-free DMEM for the indicated time periods (e). Values are presented as mean ± s.d., n = 3 for each treatment; * P = 0.0187, FBP levels in cells incubated in 10 mM glucose (for 1 h) were compared to those in cells incubated with media containing 5 mM glucose (for 1 h); †P = 0.0102, cells incubated with media containing 5 mM to 3 mM glucose (for 1 h); P = 0.831, cells incubated with medium containing 25 mM to 10 mM glucose (for 1 h); P = 0.00577, comparison of incubation in glucose-free medium for 0 min to 20 min (ANOVA). f, Plasma glucose concentrations (left) and intracellular FBP levels (right) in mouse liver. FBP were determined by CE-MS analysis. Results are mean ± s.d., n = 6 for each condition; P value by Student's t-test. g, h, Linear correlation between extracellular glucose concentrations and intracellular FBP levels. FBP levels in MEFs, measured after 2 h of incubation in media containing various concentrations of glucose as shown in d, and in the starved mouse liver shown in f, were plotted against their corresponding glucose concentrations in the culture medium (g) and plasma (h), respectively. i, FBP levels in SLO-permeabilized MEFs. Levels of FBP in regularly cultured SLO-permeabilized MEFs (left panel), or glucose-starved SLO-permeabilized MEFs treated with exogenous FBP (right panel), were determined by CE-MS analysis. Results are mean ± s.d., n = 3 for each condition. * * * P < 0.001, N.S., not significant by Student's t-test (left panel) and ANOVA (right panel). Experiments shown in left and right panels were performed simultaneously and shared a single control (SLO-permeabilized MEFs incubated in medium containing 25 mM glucose). j-l, Addition of exogenous FBP to permeabilized MEFs blocks glucose starvation-induced AMPK activation. Various glycolytic intermediates (200 μ M) as indicated were individually added to the 2-h glucose-starved wild-type (j), PFK1-KD (k) or TPI-KD (l) MEFs pre-incubated with SLO for 5 min. After incubating for another 15 min, cells were lysed and were analysed by immunoblotting. Experiments in this figure were performed twice.
Extended Data Figure 10 | Aldolase interacts with the v-ATPaseragulator complex. a, A simplified model depicting the idea that aldolase is a sensor of glucose availability that directly links glucose shortage to activation of AMPK. b, HEK293T cells were lysed and the endogenous aldolase was immunoprecipitated, followed by immunoblotting. The experiment was performed twice.
